Article
Novel inhibitors of human immunodeficiency virus type 2 infectivity
8 Aug 2014
Abstract excerpt
Human immunodeficiency virus type 2 (HIV-2) infects about two million people worldwide. HIV-2 has fewer treatment options than HIV-1, yet may evolve drug resistance more quickly. We have analysed several novel drugs for anti-HIV-2 activity. It was observed that 5-azacytidine, clofarabine, gemcitabine and resveratrol have potent anti-HIV-2 activity. The EC50 values for 5-azacytidine, clofarabine and resveratrol...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
